Sign in
Back
Preferential Initiation of Long-Acting Injectable Versus Oral HIV Pre-Exposure Prophylaxis Among Women Who Inject Drugs
Journal article   Peer reviewed

Preferential Initiation of Long-Acting Injectable Versus Oral HIV Pre-Exposure Prophylaxis Among Women Who Inject Drugs

Alexis M Roth, Tyler S Bartholomew, Kathleen M Ward, Allison Groves, Silvana Mazzella, Scarlett Bellamy, K Rivet Amico, Adam W Carrico, Gail Ironson and Douglas Krakower
Clinical infectious diseases
2024-09-30
DOI: https://doi.org/10.1093/cid/ciae450
PMID: 39347705
Appears in  Miller School of Medicine - Latest Publications

Abstract

pre-exposure prophylaxis HIV prevention long-acting injectable cabotegravir women who inject drugs
Fifty-five of 62 women who inject drugs (WWID) selected long-acting cabotegravir (CAB-LA) over oral PrEP, and 51/55 received a first injection. More recent injection drug use and number of sexual partners were associated with selecting CAB-LA (P < .05). Findings provide preliminary evidence of a strong preference for longer-acting products among WWID.

Metrics

1 Record Views

Details